propafenone has been researched along with vernakalant in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avetisyan, R; Bash, LD; Buono, JL; Davies, GM; Fahrbach, K; Martin, A; Mwamburi, M; Phatak, H | 1 |
| Aragon, M; Caro, M; Conde, D; Costabel, JP; Ferro, A; Giniger, A; Klein, A; Trivi, M | 1 |
| Aragon, M; Conde, D; Corrales Barbosa, A; Costabel, JP; Giniger, A; Klein, A; Lambardi, F; Trivi, M | 1 |
| Conde, D | 1 |
| Aragon, M; Conde, D; Costabel, JP; Lambardi, F; Trivi, M | 1 |
| Baranchuk, A; Chiale, PA; Conde, D; de Luna, AB; Enriquez, A; Hopman, W; Mondragon, I | 1 |
1 review(s) available for propafenone and vernakalant
| Article | Year |
|---|---|
Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
Topics: Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Bayes Theorem; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Pyrrolidines; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
1 trial(s) available for propafenone and vernakalant
| Article | Year |
|---|---|
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
Topics: Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Length of Stay; Male; Middle Aged; Propafenone; Prospective Studies; Pyrrolidines | 2013 |
4 other study(ies) available for propafenone and vernakalant
| Article | Year |
|---|---|
Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
Topics: Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Europe; Flecainide; Humans; Practice Guidelines as Topic; Propafenone; Pyrrolidines | 2013 |
Conversion of recent onset atrial fibrillation: which drug is faster?
Topics: Administration, Oral; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Injections, Intravenous; Propafenone; Pyrrolidines; Time Factors | 2013 |
Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
Topics: Administration, Oral; Aged; Anisoles; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flecainide; Health Status; Humans; Injections, Intravenous; Male; Middle Aged; Perception; Propafenone; Prospective Studies; Pyrrolidines; Quality of Life; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2014 |
Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.
Topics: Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Electrocardiography; Female; Heart Block; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Propafenone; Pyrrolidines; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2014 |